Tag: 340b drug pricing

The Trump Administration and the Effect on the 340B Drug Program

The 340B Drug Program may experience some changes due to the new administration and Republican congress. Some anticipate that drug manufacturers interests will be addressed rather than the concerns of health plans or providers. Whether this is true has yet

Posted in 340B Program Tagged with: , , ,

Get Ready for A HRSA 340B Program Audit

Many covered entities (“CE”)  have already experienced the Health Resources and Services Administration (“HRSA”) audit procedure. If your CE hasn’t already experienced a HRSA review yet, be assured it’s coming to you and perhaps sometime soon. 340B Program Audit Basics

Posted in 340B Program Tagged with: , ,

340B Drug Pricing Program ‘Mega Guidance’ – Key Takeaways

HRSA has released guidance on the 340B drug pricing program. The guidance will likely be published in the Federal Register late summer. While the guidance addresses a range of topics, it will presumably focus on the definition of patient, contract pharmacy

Posted in 340B Program Tagged with: , , ,

HRSA Updates 340B Drug Pricing Program Audit Practices

As the Health Resources and Services Administration (HRSA) carries on to improve their function in the 340B drug pricing program administration, they have crafted three modifications which will affect covered entities. While the overall process continues to be mostly unchanged, recently-announced improvements

Posted in 340B Program Tagged with: , , ,